789 related articles for article (PubMed ID: 16010849)
1. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents.
Salama SM; Atwal H; Gandhi A; Simon J; Poglod M; Montaseri H; Khan JK; Furukawa T; Saito H; Nishida K; Higashitani F; Uji T; Unemi N; Daneshtalab M; Micetich RG
Antimicrob Agents Chemother; 2001 Sep; 45(9):2420-6. PubMed ID: 11502508
[TBL] [Abstract][Full Text] [Related]
3. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
[TBL] [Abstract][Full Text] [Related]
4. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
Shi J; Li S; Gao A; Zhu K; Zhang H
Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.
Tsuchimori N; Hayashi R; Kitamoto N; Asai K; Kitazaki T; Iizawa Y; Itoh K; Okonogi K
Antimicrob Agents Chemother; 2002 May; 46(5):1388-93. PubMed ID: 11959573
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Sun L; Liao K; Hang C
Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
Kamai Y; Harasaki T; Fukuoka T; Ohya S; Uchida K; Yamaguchi H; Kuwahara S
Antimicrob Agents Chemother; 2002 Feb; 46(2):367-70. PubMed ID: 11796343
[TBL] [Abstract][Full Text] [Related]
8. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Lu Y; Zhou Z; Mo L; Guo Q; Peng X; Hu T; Zhou X; Ren B; Xu X
Appl Microbiol Biotechnol; 2019 Aug; 103(16):6701-6709. PubMed ID: 31201451
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
[TBL] [Abstract][Full Text] [Related]
12. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.
Elizondo-Zertuche M; Robledo-Leal E; González JG; Ceceñas LA; González GM
Rev Iberoam Micol; 2015; 32(1):30-3. PubMed ID: 24071640
[TBL] [Abstract]
